Sandbox:MDS: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) (Created page with "{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" |valign=top| |+ ! style="background: #4479BA; width: 250px; color: #FFFFFF;"|'''Name''' ! style="background...") |
Nawal Muazam (talk | contribs) No edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 13: | Line 13: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with ring sideroblasts'''|| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with ring sideroblasts (RARS)'''| | ||
| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:* Less than 5% myeloblasts in the bone marrow, but distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts. | :* Less than 5% myeloblasts in the bone marrow, but distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with excess blasts'''|| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with excess blasts (RAEB)'''|| style="padding: 5px 5px; background: #F5F5F5;"| | ||
:* 5-20% myeloblasts in the marrow | :* 5-20% myeloblasts in the marrow. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with excess blasts in transformation'''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with excess blasts in transformation (RAEB-T)'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:*21-30% myeloblasts in the marrow (>30% blasts is defined as acute myeloid leukemia) | :*21-30% myeloblasts in the marrow (>30% blasts is defined as acute myeloid leukemia). | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Chronic myelomonocytic leukemia'''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Chronic myelomonocytic leukemia (CMML)'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:*Less than 20% myeloblasts in the bone marrow and greater than 1*109/L monocytes in peripheral blood. | :*Less than 20% myeloblasts in the bone marrow and greater than 1*109/L monocytes in peripheral blood. | ||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Old system''' | |||
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''New system''' | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia]]''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Refractory cytopenia with unilineage dysplasia | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with ringed sideroblasts]]''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Refractory anemia with ring sideroblasts | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
|style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Refractory cytopenia with multilineage dysplasia | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with excess blasts]]''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Refractory anemias with excess blasts I and II | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with excess blasts in transformation]] I–IV ''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
5q - syndrome | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Chronic myelomonocytic leukemia]]''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Myelodysplastic-myeloproliferative overlap syndromes | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Refractory cytopenia of childhood | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | |||
Unclassifiable myelodysplastic syndrome | |||
|} | |} |
Latest revision as of 15:06, 8 December 2015
Name | Description |
---|---|
Refractory anemia |
|
Refractory anemia with ring sideroblasts (RARS)| |
|
Refractory anemia with excess blasts (RAEB) |
|
Refractory anemia with excess blasts in transformation (RAEB-T) |
|
Chronic myelomonocytic leukemia (CMML) |
|
Old system | New system |
---|---|
Refractory anemia |
Refractory cytopenia with unilineage dysplasia |
Refractory anemia with ringed sideroblasts |
Refractory anemia with ring sideroblasts |
Refractory cytopenia with multilineage dysplasia | |
Refractory anemia with excess blasts |
Refractory anemias with excess blasts I and II |
Refractory anemia with excess blasts in transformation I–IV |
5q - syndrome |
Chronic myelomonocytic leukemia |
Myelodysplastic-myeloproliferative overlap syndromes |
Refractory cytopenia of childhood | |
Unclassifiable myelodysplastic syndrome |